Aspirin in the primary prevention of vascular disease.
Jankowski
Janusz
J
Attwood
Stephen
S
deCaestecker
John
J
Barr
Hugh
H
D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use*; D001471:Barrett Esophagus / Q000517:prevention & control; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011322:Primary Prevention / Q000379:methods*; D014652:Vascular Diseases / Q000517:prevention & control*
D000897:Anti-Ulcer Agents; D010975:Platelet Aggregation Inhibitors; D009853:Omeprazole; D001241:Aspirin